ANTIDIABETIC AGENTS > K-MET-Duo Tablets
For the use of a Registered Medical Practitioner, a Hospital or a Laboratory only.
COMPOSITION
K-MET-Duo 0.2 mg Tablets
Each uncoated bilayered tablet contains:
Metformin HCL IP (as sustained release) 500 mg
Voglibose IP 0.2 mg
 
K-MET-Duo 0.3 mg Tablets
Each uncoated bilayered tablet contains:
Metformin HCL IP (as sustained release) 500 mg
Voglibose IP 0.3 mg
 
INDICATIONS
K-MET Duo Tablets are indicated as 2nd line treatment for type 2 diabetes mellitus when diet, exercise and the single agent do not result in adequate glycemic control.
DOSAGE AND ADMINISTRATION
Oral: Adults: 1 tablet to be administered twice or thrice daily, just before each meal. Or, as prescribed by the physician.
  • Metformin: Maximum daily dose – 2 g in divided dosage.
  • Voglibose: Maximum daily dose - 1.8 mg in divided dosage.
HOW SUPPLIED
10 Tablets per strip.